News Detail
IIT Roorkee, 17 March 2025: Scientists at the Indian Institute of Technology (IIT) Roorkee have studied a new possibility for treating Chikungunya, a mosquito-borne viral disease that causes fever, joint pain, muscle pain, and rash. Their research indicates that Efavirenz, a......
View Details
Source : IIT Roorkee
Indian Institute of Technology (IIT) Roorkee
treating Chikungunya
Efavirenz
Related News
- Mandimycin: A polyene antifungal with a unique mode of action (22-03-2025)
- Newly identified bacterial protein helps design cancer drug delivery system (21-03-2025)
- New test enables doctors to anticipate a serious side effect of cancer therapy (17-03-2025)
- Chinese vaccine shows promise in stopping plaque build-up in arteries (15-03-2025)
- Researchers develop technique for storing life-saving drugs without temperature control (15-03-2025)
- NIT researchers develop eco-friendly process to remove pharmaceutical pollutants from wastewater (14-03-2025)
- New personalised vaccine shows promise in treating deadly pancreatic cancer (13-03-2025)
- Human body's protein recycling system fights bacteria like antibiotics: Study (06-03-2025)
- Researchers at IIT Kanpur Identify Crucial Drug Target Receptor for Treating Cancer and Respiratory Diseases (22-02-2025)
- Polymer coating designed to prevent blood clot formation on medical implants (21-02-2025)